What is Decentralized clinical trials?:Benefits and challenges of implementing DCT

FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US

FDA Clears First Over-the-Counter Continuous Glucose Monitor

FDA, Industry Actions End Sales of PFAS Used in US Food Packaging

Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL

BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases